A Phase II study evaluating safety and efficacy of ribociclib and everolimus in patients with thyroid cancer
Latest Information Update: 24 Jun 2017
At a glance
- Drugs Everolimus (Primary) ; Ribociclib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 24 Jun 2017 New trial record
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology